81 related articles for article (PubMed ID: 1199156)
1. [Polycytostatic treatment of highly aggressive thyroid malignomas].
Zechmann W; Riccabona G
Z Allgemeinmed; 1975 Oct; 51(29):1304-7. PubMed ID: 1199156
[No Abstract] [Full Text] [Related]
2. [Non-surgical treatment of thyroid neoplasms].
Klepp O
Tidsskr Nor Laegeforen; 1975 Aug; 95(23):1287-90. PubMed ID: 1179338
[No Abstract] [Full Text] [Related]
3. Chemotherapy in carcinoma of the thyroid: retrospective and prospective.
Alexieva-Figusch J; Van Gilse HA; Treurniet RE
Ann Radiol (Paris); 1977; 20(8):810-3. PubMed ID: 610553
[No Abstract] [Full Text] [Related]
4. Radioiodine therapy and age at menopause in patients with thyroid cancer.
Rosario PW; Fagundes TA; Fagundes AV; Barraso AL; Rezende LL; Padrao EL; Guimaraes VC; Purisch S
Clin Endocrinol (Oxf); 2006 Feb; 64(2):225-6. PubMed ID: 16430725
[No Abstract] [Full Text] [Related]
5. Coming of age: recombinant human thyroid-stimulating hormone as a preparation for (131)i therapy in thyroid cancer.
Robbins RJ; Pentlow KS
J Nucl Med; 2003 Jul; 44(7):1069-71. PubMed ID: 12843222
[No Abstract] [Full Text] [Related]
6. [Conservative therapy of thyroid tumors ].
Kuma K; Matsuzuka F
Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):905-9. PubMed ID: 2230471
[No Abstract] [Full Text] [Related]
7. Thyroid neoplasia.
Curran PG; DeGroot LJ
Curr Ther Endocrinol Metab; 1994; 5():108-12. PubMed ID: 7704691
[No Abstract] [Full Text] [Related]
8. [Medical treatment of bone metastases].
Tubiana-Hulin M
Bull Cancer Radiother; 1996; 83(4):299-304. PubMed ID: 9081331
[No Abstract] [Full Text] [Related]
9. Treatment of metastatic thyroid cancer.
Leeper RD; Shimaoka K
Clin Endocrinol Metab; 1980 Jul; 9(2):383-404. PubMed ID: 6994947
[No Abstract] [Full Text] [Related]
10. [Treatment of thyroid carcinoma].
Lamberg BA; Torsti R
Duodecim; 1976; 92(24):1415-30. PubMed ID: 1009860
[No Abstract] [Full Text] [Related]
11. Results of [131I]metaiodobenzylguanidine therapy administered to two patients with medullary carcinoma of the thyroid.
Schvartz C; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):332-3. PubMed ID: 1823850
[TBL] [Abstract][Full Text] [Related]
12. [The use of 131I in the combined modality therapy of highly differentiated cancer of the thyroid gland].
Baranauskas ZL; Mamontov VV; Valutskas KK
Med Radiol (Mosk); 1989 Oct; 34(10):31-4. PubMed ID: 2811625
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of differentiated thyroid carcinomas. Clinical results and effects on the granulocytic stem cell (CFUc) compartment.
Droz JP; Morardet N; Charbord P; Maraninchi D; Hayat M; Parmentier C
Ann Radiol (Paris); 1977; 20(8):814-8. PubMed ID: 610554
[No Abstract] [Full Text] [Related]
14. [Treatment and follow-up of thyroid cancer].
Välimäki M
Duodecim; 1991; 107(6):456-60. PubMed ID: 1364893
[No Abstract] [Full Text] [Related]
15. [Radioactive iodine in the treatment of thyroid carcinoma].
Pendić S; Tasić S
Srp Arh Celok Lek; 1980 Oct; 108(10):1021-9. PubMed ID: 7292160
[No Abstract] [Full Text] [Related]
16. Session on: has [131I]metaiodobenzylguanidine a role in the treatment of medullary thyroid cancer and carcinoid tumors? Chairman's report.
Bestagno M
J Nucl Biol Med (1991); 1991; 35(4):355-6. PubMed ID: 1823857
[No Abstract] [Full Text] [Related]
17. [Chemotherapy of thyroid carcinoma (author's transl)].
Brunner K
Schweiz Rundsch Med Prax; 1982 Apr; 71(14):603-5. PubMed ID: 7201137
[No Abstract] [Full Text] [Related]
18. [Evaluation of effects of L-thyroxine therapy in differentiated thyroid carcinoma on the cardiovascular system --prospective study].
Matuszewska G; Roskosz J; Włoch J; Jurecka-Tuleja B; Hasse-Lazar K; Kowalczyk P; Jarzab B
Wiad Lek; 2001; 54 Suppl 1():373-7. PubMed ID: 12182052
[TBL] [Abstract][Full Text] [Related]
19. Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.
Juweid ME; Hajjar G; Stein R; Sharkey RM; Herskovic T; Swayne LC; Suleiman S; Pereira M; Rubin AD; Goldenberg DM
J Nucl Med; 2000 Jan; 41(1):93-103. PubMed ID: 10647610
[TBL] [Abstract][Full Text] [Related]
20. [Clinical remission and reduction of malignant pheochromocytoma treated with iodine-131-meta-iodobenzylguanidine].
Piñero A; Hernández A; Rodríguez JM; Parrilla P
Med Clin (Barc); 1996 Nov; 107(19):755-6. PubMed ID: 9082096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
